uBriGene and Cellinfinity BIO collaborate to accelerate in vivo CAR-T therapies
uBriGene Biosciences has signed a strategic partnership with Cellinfinity BIO to advance the clinical development of in vivo chimeric antigen …
Post
-
-
ACC 2026: Baxdrostat lowers BP in uncontrolled hypertension
At the 2026 American College of Cardiology (ACC) Scientific Session in New Orleans, researchers presented a meta-analysis of randomized trials …
-
ACC 2026: Lorundrostat lowers BP but raises hyperkalemia risk
At the 2026 American College of Cardiology (ACC) Scientific Session in New Orleans, investigators from Brazil presented a systematic review …
-
From compliance to culture: Lessons from a quality leader on pharma’s next imperative
We spoke with Grace Breen, Senior Vice President, Quality at Sharp about the role of quality in a CDMO environment, …
-
The future of healthcare in America: what to expect in the next decade
The healthcare landscape has undergone a rapid transformation worldwide over the past decade. COVID-19 played a massive role in the …
-
ACC 2026: Baxdrostat lowers BP in uncontrolled hypertension
At the 2026 American College of Cardiology (ACC) Scientific Session in New Orleans, researchers presented a meta-analysis of randomized trials …
-
ACC 2026: Lorundrostat lowers BP but raises hyperkalemia risk
At the 2026 American College of Cardiology (ACC) Scientific Session in New Orleans, investigators from Brazil presented a systematic review …
-
From compliance to culture: Lessons from a quality leader on pharma’s next imperative
We spoke with Grace Breen, Senior Vice President, Quality at Sharp about the role of quality in a CDMO environment, …
-
The future of healthcare in America: what to expect in the next decade
The healthcare landscape has undergone a rapid transformation worldwide over the past decade. COVID-19 played a massive role in the …
-
The crucial role of payload linker innovation in the growth of ADCs
Combining the specificity of monoclonal antibodies with the potency of cytotoxic payloads, ADCs enable targeted delivery of therapeutics to diseased …
-
Merck’s strategic shift: acquires Terns for $6.7bn, targeting dominance in CML
On 25 March, Merck (MSD) announced the $6.7bn acquisition of Terns Pharmaceuticals via a subsidiary, as part of its strategic …
-
Otsuka agrees to acquire Transcend Therapeutics for $1.22bn
Otsuka Pharmaceutical has signed an agreement to fully acquire Transcend Therapeutics through its subsidiary Otsuka America for a potential consideration …
-
Eli Lilly and Insilico Medicine forge $2.75bn AI-driven R&D pact
Eli Lilly is joining forces with artificial intelligence (AI)-powered biotech, Insilico Medicine, in a drug discovery and development agreement worth …
-
Novo Nordisk receives FDA approval for basal insulin Awiqli
Novo Nordisk has secured the US Food and Drug Administration (FDA) approval for Awiqli (insulin icodec-abae) injection 700 units/mL, a …
-
Recordati sizes up €10.9bn CVC Capital acquisition offer
Italian pharmaceutical company, Recordati, has confirmed that it’s weighing an acquisition offer from private equity manager, CVC, which is looking …
